Investor profile
Embryo Ventures
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Embryo Ventures believes in the 'Power of Beginnings' — partnering with the most exceptional founders at the origin of their ventures to champion ambitious pursuits that redefine the lived experience across the fundamental dimensions of human life. The firm invests across two core pillars: Human Health (backing next-generation clinical and consumer technologies that restore, sustain, and expand human health and potential — spanning surgical/diagnostic innovations, chronic condition management, and frontier healthspan technologies) and Human Experience (investing thematically in the essential infrastructure of daily life, including connectivity, mobility, care, safety, and built environments). Embryo operates at pre-seed and seed stages, primarily in the UK and Europe with opportunistic global reach, focusing on technical founders solving hard problems in deeptech, healthtech, AI, and frontier science.
Notable quotes
“I invest in Healthtech, Deeptech and Frontier innovations shaping the future of human health and experience.”
“At Embryo Ventures we're actively investing pre-seed and seed into technical founders building frontier technology and defensible healthcare innovation. The ideas we're most excited about right now: Control of our Biology, Expanding physical and cognitive potential, Removing the friction that quietly dominates daily life, Technologies that change what humans can do.”
“Dr Arash Moavenian is a London-based venture investor focused on pioneering companies reshaping the future of human health and experience. Arash partners with the world's most exceptional founders operating at the intersection of the intellectual and real-world economies – pursuing opportunities to deliver direct, measurable and long-term impact across physical, social and environmental dimensions of our world.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| OSSTEC | Seed | $3m | 2026-02 |
| Gladys | Seed | $2m | 2025-10 |
| STAXY | Seed | — | 2025-10 |
| Bridgefy | Seed | — | — |
| IMPLI | Pre-seed | — | — |
| Calla Lily Clinical Care | Pre-seed | — | — |
| BioLumen | Seed | — | — |
| LAKA | Seed | — | — |
| Thermulon | Seed | — | — |
| Cheeky Panda | Seed | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Cornerstone VC | 1 |
| Exceptional Ventures | 1 |
| Ufi Ventures | 1 |
| Houghton Street Ventures | 1 |
| The Conduit EIS Impact Fund | 1 |
| FSE Group | 1 |
Fit check
Is Embryo Ventures a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit